top of page
When the needle tip enters the epidural space and loss of resistance is detected, EpiZact triggers and automatically stops the forward progress of the needle, positioning the needle tip exactly in the epidural space.
EpiZact aims to add a margin of safety that has never existed before, reducing the chance of accidental dural puncture, improving patient satisfaction, and delivering cost savings for healthcare providers.
Key Benefits
Automatically stops the needle when loss of resistance is detected.
Improved patient safety and satisfaction by aiming to eliminate accidental dural puncture.
Significant cost savings by avoiding PDPH treatment expenses.
Suitable for lumbar, thoracic and cervical epidurals.
EpiZact is FDA Cleared
1
Primed
Triggered
Continuity
EpiZact is easily incorporated into the epidural procedure. It does not disrupt existing flow.
Tactile Feedback
Retain tactile feel when advancing the needle. Have control over the procedure.
STOPS the Needle
Detects loss of resistance and stops the needle in the epidural space.
1. FDA 510(k) Number K233056
bottom of page